|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||15.88 - 16.55|
|52 Week Range||14.61 - 28.19|
|Beta (3Y Monthly)||1.00|
|PE Ratio (TTM)||8.95|
|Forward Dividend & Yield||0.78 (5.00%)|
|1y Target Est||N/A|
NEW ORLEANS, March 25, 2019 /PRNewswire/ -- The makers of the popular blood thinner Xarelto® have reached a $775 million settlement to resolve litigation filed by patients who suffered a bleeding injury after taking the prescription drug. According to the agreement announced earlier today between plaintiff lawyer leadership and Bayer Healthcare (BAYRY) and Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson (JNJ), the settlement is a private agreement intended to resolve the entire litigation including cases in federal and state courts. "This is a fair and just resolution for thousands of consumers who have substantial claims," says Andy Birchfield of the Beasley Allen law firm and co-lead counsel of the Plaintiffs' Steering Committee for the federal multidistrict litigation.
Wiivv announced today at CES that it is partnering with Dr. Scholl’s, the category leader in foot care, to help expand the 112-year old brand’s business into custom 3D printed insoles, powered by Wiivv Fit Technology. Using a simple smartphone app, consumers can personalize their own design and order--on-demand from their living room--a Dr. Scholl’s Custom 3D printed insole mapped from 400 points on their feet. “Dr. Scholl‘s understands the importance of customization for a growing number of consumers.
NEW YORK, NY / ACCESSWIRE / August 27, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTC PINK: BAYRY). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 9980. The investigation concerns whether Bayer and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
NEW YORK , Aug. 20, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bayer Aktiengesellschaft ("Bayer" ...